Metformin upregulates the expressions of lncRNA MALAT1 and ER stress genes, while MALAT1 knockdown in metformin-treated breast cancer cells shows reduced phosphorylation of c-Myc [130]. Here, MALAT1 is linked to breast carcinoma.